Cannabis Bioscience International Holdings, Inc. (CBIH)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jul 27, 2026, 1:03 PM EST
CBIH Balance Sheet
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Cash & Equivalents | 0 | 0.01 | 0 | 0.01 | 0.03 | 0.04 |
Cash & Short-Term Investments | 0 | 0.01 | 0 | 0.01 | 0.03 | 0.04 |
Cash Growth | -83.58% | 1615.50% | -91.53% | -72.13% | -22.60% | -67.63% |
Accounts Receivable | 0 | 0.01 | 0.02 | 0.01 | 0.01 | 0 |
Other Receivables | - | 0.01 | - | - | 0.01 | - |
Receivables | 0 | 0.02 | 0.02 | 0.01 | 0.02 | 0 |
Other Current Assets | 0 | 0 | 0 | 0 | - | 0.01 |
Total Current Assets | 0 | 0.03 | 0.02 | 0.02 | 0.05 | 0.05 |
Property, Plant & Equipment | - | 0 | 0.04 | 0.02 | 0.06 | 0.09 |
Total Assets | 0 | 0.03 | 0.06 | 0.04 | 0.11 | 0.15 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Accounts Payable | 0.19 | 0.1 | 0.17 | 0.11 | 0.07 | 0.02 |
Accrued Expenses | 0.03 | 0.02 | - | - | - | - |
Short-Term Debt | 0.96 | 0.74 | 0.66 | 0.23 | 0.09 | 0.09 |
Current Portion of Long-Term Debt | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 |
Current Portion of Leases | - | 0 | 0.02 | 0 | 0.04 | 0.04 |
Current Unearned Revenue | - | - | - | 0.03 | - | - |
Other Current Liabilities | 0.03 | 0.06 | 0.03 | - | 0.02 | 0.01 |
Total Current Liabilities | 1.22 | 0.95 | 0.88 | 0.39 | 0.22 | 0.19 |
Long-Term Debt | 0.25 | 0.25 | 0.25 | 0.25 | 0.24 | 0.22 |
Long-Term Leases | - | - | 0 | - | 0 | 0.04 |
Other Long-Term Liabilities | - | - | -0 | - | - | - |
Total Liabilities | 1.47 | 1.2 | 1.14 | 0.64 | 0.47 | 0.45 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Additional Paid-In Capital | 4.72 | 4.72 | 4.26 | 4.09 | 3.29 | 2.46 |
Retained Earnings | -6.19 | -5.88 | -5.33 | -4.68 | -3.65 | -2.76 |
Total Common Equity | -1.47 | -1.16 | -1.08 | -0.59 | -0.36 | -0.3 |
Shareholders' Equity | -1.47 | -1.16 | -1.08 | -0.59 | -0.36 | -0.3 |
Total Liabilities & Equity | 0 | 0.03 | 0.06 | 0.04 | 0.11 | 0.15 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
Total Debt | 1.22 | 1.01 | 0.94 | 0.5 | 0.39 | 0.42 |
Net Cash (Debt) | -1.22 | -1 | -0.94 | -0.49 | -0.35 | -0.38 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Filing Date Shares Outstanding | 11,627 | 11,627 | 10,432 | 10,060 | 8,613 | 7,814 |
Total Common Shares Outstanding | 11,627 | 11,627 | 10,432 | 10,060 | 8,613 | 7,814 |
Working Capital | -1.22 | -0.92 | -0.86 | -0.37 | -0.17 | -0.13 |
Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Tangible Book Value | -1.47 | -1.16 | -1.08 | -0.59 | -0.36 | -0.3 |
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |